As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
True growth isn’t linear — it’s exponential, and thinking in zeros means setting bold targets and creating systems that multiply impact instead of adding it slowly.
Whoop founder Will Ahmed has spent 14 years building a health wearable beloved by elite athletes, and is now racing Oura — and the FDA, and the limits of consumer medicine — to turn it into something that could one day save your life.
True growth isn’t linear — it’s exponential, and thinking in zeros means setting bold targets and creating systems that multiply impact instead of adding it slowly.
True growth isn’t linear — it’s exponential, and thinking in zeros means setting bold targets and creating systems that multiply impact instead of adding it slowly.
True growth isn’t linear — it’s exponential, and thinking in zeros means setting bold targets and creating systems that multiply impact instead of adding it slowly.